標(biāo)題: Titlebook: Statistical Research Methods; A Guide for Non-Stat Roy Sabo,Edward Boone Textbook 2013 Springer Science+Business Media New York 2013 Biosta [打印本頁(yè)] 作者: 佯攻 時(shí)間: 2025-3-21 17:45
書(shū)目名稱(chēng)Statistical Research Methods影響因子(影響力)
書(shū)目名稱(chēng)Statistical Research Methods影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Statistical Research Methods網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Statistical Research Methods網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Statistical Research Methods被引頻次
書(shū)目名稱(chēng)Statistical Research Methods被引頻次學(xué)科排名
書(shū)目名稱(chēng)Statistical Research Methods年度引用
書(shū)目名稱(chēng)Statistical Research Methods年度引用學(xué)科排名
書(shū)目名稱(chēng)Statistical Research Methods讀者反饋
書(shū)目名稱(chēng)Statistical Research Methods讀者反饋學(xué)科排名
作者: itinerary 時(shí)間: 2025-3-21 20:36 作者: 缺陷 時(shí)間: 2025-3-22 02:28 作者: Resistance 時(shí)間: 2025-3-22 08:03
Roy Sabo,Edward Boone and Recent Advances. aims to help researchers to develop safer and more effective PPAR modulators as therapeutic agents to treat a myriad of diseases and conditions.978-1-62703-886-7978-1-62703-420-3作者: IVORY 時(shí)間: 2025-3-22 10:47
Roy Sabo,Edward Boone and Recent Advances. aims to help researchers to develop safer and more effective PPAR modulators as therapeutic agents to treat a myriad of diseases and conditions.978-1-62703-886-7978-1-62703-420-3作者: diabetes 時(shí)間: 2025-3-22 15:15 作者: AXIOM 時(shí)間: 2025-3-22 20:28
Roy Sabo,Edward Boone and Recent Advances. aims to help researchers to develop safer and more effective PPAR modulators as therapeutic agents to treat a myriad of diseases and conditions.978-1-62703-886-7978-1-62703-420-3作者: Bridle 時(shí)間: 2025-3-22 23:51 作者: 貞潔 時(shí)間: 2025-3-23 04:14
and Recent Advances. aims to help researchers to develop safer and more effective PPAR modulators as therapeutic agents to treat a myriad of diseases and conditions.978-1-62703-886-7978-1-62703-420-3作者: falsehood 時(shí)間: 2025-3-23 07:08 作者: Range-Of-Motion 時(shí)間: 2025-3-23 12:33 作者: Lucubrate 時(shí)間: 2025-3-23 14:53 作者: 膽汁 時(shí)間: 2025-3-23 19:32
Multi-category Data, measurement (Yes or No, Success or Failure, etc.). We now generalize to the case where one or more of our variables under consideration has more than two possible values. These types of polytomous or multi-category data are more complicated than their dichotomous brethren, and as such must be handl作者: 舊病復(fù)發(fā) 時(shí)間: 2025-3-23 22:48
Summarizing Continuous Data,and contingency tables. In this chapter we begin our study of ., where the measurements we will deal with are quantitative in nature. Since this type of data consists of actual numbers, we will be able to arithmetically manipulate them (this isn’t as malicious as it sounds). However, what type of ma作者: 高興去去 時(shí)間: 2025-3-24 05:19 作者: 痛苦一下 時(shí)間: 2025-3-24 09:29 作者: Perennial長(zhǎng)期的 時(shí)間: 2025-3-24 14:34
Textbook 2013ces to learn, use and communicate results from many commonly used statistical methods. The material covered, and the manner in which it is presented, describe the entire data analysis process from hypothesis generation to writing the results in a manuscript. Chapters cover, among other topics: one a作者: characteristic 時(shí)間: 2025-3-24 16:20
Summarizing Continuous Data,of data consists of actual numbers, we will be able to arithmetically manipulate them (this isn’t as malicious as it sounds). However, what type of manipulation we perform depends – of course – on the type of question we’re attempting to answer, as well as the nature of the data itself.作者: 得意牛 時(shí)間: 2025-3-24 19:46 作者: 小步走路 時(shí)間: 2025-3-25 00:50
Power,We have previously discussed the concepts of Type I and Type II errors, but we have not much considered their relevance to study design and statistical analysis. In practice, controlling either the type II error rate or the power – holding all other components fixed – will determine the sample size needed to find a significant result.作者: Alpha-Cells 時(shí)間: 2025-3-25 06:07
Association and Regression,One of the assumptions we have required for nearly every test we’ve conducted thus far is that of independent subject measurements. The “independence” in question implies that subjects are measured without influencing each other.作者: ablate 時(shí)間: 2025-3-25 07:45 作者: Obedient 時(shí)間: 2025-3-25 13:26 作者: myopia 時(shí)間: 2025-3-25 18:16
Multi-category Data, measurement (Yes or No, Success or Failure, etc.). We now generalize to the case where one or more of our variables under consideration has more than two possible values. These types of polytomous or multi-category data are more complicated than their dichotomous brethren, and as such must be handled differently.作者: Oligarchy 時(shí)間: 2025-3-25 22:41 作者: Little 時(shí)間: 2025-3-26 00:29 作者: Lumbar-Stenosis 時(shí)間: 2025-3-26 06:45
https://doi.org/10.1007/978-1-4614-8708-1Biostatistics; Health care statistics; Non-Statisticians; Research Methods; Statistical Inference; Statis作者: Filibuster 時(shí)間: 2025-3-26 11:31 作者: 鞭子 時(shí)間: 2025-3-26 14:02 作者: 職業(yè) 時(shí)間: 2025-3-26 20:03 作者: 抗體 時(shí)間: 2025-3-26 23:01
Roy Sabo,Edward Booneors as therapeutic agents.Serves as an excellent companion t.All three peroxisome proliferator-activated receptor (PPAR) subtypes share a high degree of structural homology while exhibiting differences in function, tissue distribution, and ligand specificity. In .Peroxisome Proliferator-Activated Re作者: 進(jìn)步 時(shí)間: 2025-3-27 04:24
Roy Sabo,Edward Booneors as therapeutic agents.Serves as an excellent companion t.All three peroxisome proliferator-activated receptor (PPAR) subtypes share a high degree of structural homology while exhibiting differences in function, tissue distribution, and ligand specificity. In .Peroxisome Proliferator-Activated Re作者: Myofibrils 時(shí)間: 2025-3-27 08:18
Roy Sabo,Edward Booneors as therapeutic agents.Serves as an excellent companion t.All three peroxisome proliferator-activated receptor (PPAR) subtypes share a high degree of structural homology while exhibiting differences in function, tissue distribution, and ligand specificity. In .Peroxisome Proliferator-Activated Re作者: Baffle 時(shí)間: 2025-3-27 11:18
Roy Sabo,Edward Booneors as therapeutic agents.Serves as an excellent companion t.All three peroxisome proliferator-activated receptor (PPAR) subtypes share a high degree of structural homology while exhibiting differences in function, tissue distribution, and ligand specificity. In .Peroxisome Proliferator-Activated Re作者: Indecisive 時(shí)間: 2025-3-27 15:16 作者: 寡頭政治 時(shí)間: 2025-3-27 17:59 作者: Fretful 時(shí)間: 2025-3-28 00:46 作者: 招募 時(shí)間: 2025-3-28 03:55
Henryk Dobslaw,Maik Thomasof MMN have been evaluated in previous studies, and it provided good results compared to the conventional interconnection network topologies. This paper will focus on evaluating and determining the static cost-effective parameter of MMN which is the product of the relation between the node degree, n作者: Genetics 時(shí)間: 2025-3-28 09:44
Comparison of Magneto-Optical Imaging with Other Local Magnetic Probesed and contrasted with those of state-of-the-art MOI where relevant. A range of examples is described emphasising applications in the area of high temperature superconductors. Finally the ways in which the existing techniques can be expected to develop over the next few years will be discussed and n作者: 膠狀 時(shí)間: 2025-3-28 11:23 作者: 主動(dòng)脈 時(shí)間: 2025-3-28 16:36
Jesse FeilerFor device developers, understanding the structure of HomeKit—homes, rooms, and accessories—enables you to build devices that are easily managed by a single, simple source and interface.With a knowled作者: Capture 時(shí)間: 2025-3-28 22:24
Course Stability and Controllability,or pulmonary angiography especially if the patient is clinically unstable at presentation. It is, thus, evident that echocardiography has gained an important diagnostic position for the management of patients with suspected pulmonary embolism.作者: 鋼筆尖 時(shí)間: 2025-3-29 01:34
